Healthcare -
Biotechnology - NASDAQ - US
$ 0.5002
-3.44 %
$ 30.9 M
Market Cap
-0.43
P/E
PASG - COST OF REVENUE
Cost of Revenue PASG - Passage Bio, Inc.
3.72 M
LAST VALUE
55.29%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR